Fig. 2
From: Novel biomarkers for monitoring and management of hepatocellular carcinoma
Novel and emerging biomarkers: EVs, CTCs, miRNAs, and ctDNA/cfRNAs are the known liquid biomarkers. These biomarkers can be detected in circulation, making them useful for non-invasive diagnostic tests. They provide valuable information about the presence and progression of diseases, helping in early detection and personalized treatment strategies